Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis

Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting

(2018) Anna Tietze et al.   JOURNAL OF NEUROSURGERY

Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: A cross-sectional observational study

(2017) Johann-Martin Hempel et al.   EUROPEAN JOURNAL OF RADIOLOGY

Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma

(2017) Arian Lasocki et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status

(2017) Rachel L. Delfanti et al.   JOURNAL OF NEURO-ONCOLOGY

Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II–III diffuse gliomas

(2017) Kevin Leu et al.   JOURNAL OF NEURO-ONCOLOGY

Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI

(2017) Shanshan Jiang et al.   MAGNETIC RESONANCE IN MEDICINE

MRI features predict survival and molecular markers in diffuse lower-grade gliomas

(2017) Hao Zhou et al.   NEURO-ONCOLOGY

MR Imaging–derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas

(2017) Andreas Stadlbauer et al.   RADIOLOGY

Less Invasive Phenotype Found in Isocitrate Dehydrogenase–mutated Glioblastomas than in Isocitrate Dehydrogenase Wild-Type Glioblastomas: A Diffusion-Tensor Imaging Study

(2017) Stephen J. Price et al.   RADIOLOGY

Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma

(2017) Zeju Li et al.   Scientific Reports

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

IDH mutations in cancer and progress toward development of targeted therapeutics

(2016) L. Dang et al.   ANNALS OF ONCOLOGY

Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma

(2016) Jinhua Yu et al.   EUROPEAN RADIOLOGY

Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status

(2016) Günther Grabner et al.   EUROPEAN RADIOLOGY

Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma

(2016) Changho Choi et al.   JOURNAL OF CLINICAL ONCOLOGY

Noninvasively detectingIsocitrate dehydrogenase 1gene status in astrocytoma by dynamic susceptibility contrast MRI

(2016) WenLi Tan et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters

(2016) Shunsuke Nakae et al.   JOURNAL OF NEURO-ONCOLOGY

Successful Publication of Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy

(2016) Chong Hyun Suh et al.   KOREAN JOURNAL OF RADIOLOGY

Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas

(2016) Biqi Zhang et al.   NEURO-ONCOLOGY

MR Imaging–Based Analysis of Glioblastoma Multiforme: Estimation ofIDH1Mutation Status

(2015) K. Yamashita et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Improved Brain Tumor Classification by Sodium MR Imaging: Prediction ofIDHMutation Status and Tumor Progression

(2015) A. Biller et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours

(2015) Ji Xiong et al.   EUROPEAN RADIOLOGY

Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers-Part I. General Guidance and Tips

(2015) Kyung Won Kim et al.   KOREAN JOURNAL OF RADIOLOGY

Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers-Part II. Statistical Methods of Meta-Analysis

(2015) Juneyoung Lee et al.   KOREAN JOURNAL OF RADIOLOGY

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma

(2015) Macarena I. de la Fuente et al.   NEURO-ONCOLOGY

Radiological features combined withIDH1status for predicting the survival outcome of glioblastoma patients

(2015) Kai Wang et al.   NEURO-ONCOLOGY

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

(2015) Jeanette E. Eckel-Passow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma

(2015) Philipp Kickingereder et al.   Scientific Reports

Radiological and Pathological Features Associated with IDH1-R132H Mutation Status and Early Mortality in Newly Diagnosed Anaplastic Astrocytic Tumours

(2015) Jason K. Wasserman et al.   PLoS One

Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas

(2014) Yukihiko Sonoda et al.   Brain Tumor Pathology

Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging

(2014) Seunghyun Lee et al.   JOURNAL OF NEURO-ONCOLOGY

Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms

(2014) SONGTAO QI et al.   Oncology Letters

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2013) Alessandro Liberati   ANNALS OF INTERNAL MEDICINE

QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

(2013) Penny F. Whiting   ANNALS OF INTERNAL MEDICINE

Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression

(2013) German Reyes-Botero et al.   NEURO-ONCOLOGY

Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma

(2012) J.A. Carrillo et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Chapter 8: Meta-analysis of Test Performance When There is a “Gold Standard”

(2012) Thomas A. Trikalinos et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas

(2012) Changho Choi et al.   NATURE MEDICINE

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

(2009) Christian Hartmann et al.   ACTA NEUROPATHOLOGICA